Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process
Myelodysplastic syndromes (MDS) are considered to be diseases associated with splicing defects. A large number of genes involved in the pre-messenger RNA splicing process are mutated in MDS. Deletion of 5q and 7q are of diagnostic value, and those chromosome regions bear the numbers of splicing gene...
Main Authors: | Nathalie Douet-Guilbert, Benoît Soubise, Delphine G. Bernard, Marie-Bérengère Troadec |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/7/1658 |
Similar Items
-
Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
by: Mohammad Faizan Zahid, et al.
Published: (2016-12-01) -
Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS)
by: Tamara Borgonovo, et al.
Published: (2005-12-01) -
A Case of SF3B1-Positive Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis
by: Alejandro Lazo-Langner, et al.
Published: (2019-02-01) -
Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
by: M. N. Pautova, et al.
Published: (2024-09-01) -
Immune Dysfunction, Cytokine Disruption, and Stromal Changes in Myelodysplastic Syndrome: A Review
by: Olivia F. Lynch, et al.
Published: (2022-02-01)